2024-09-08 - Analysis Report
## HCA Stock Analysis Report

**Company:** HCA Healthcare, Inc. (HCA) - One of the largest healthcare providers in the United States, operating over 180 hospitals and 2,000 care sites across the country.

**1. Performance Comparison:**

* **HCA's cumulative return:** 164.24%
* **S&P 500 (VOO) cumulative return:** 81.34%
* **Performance Gap:** 82.9% (representing a significant outperformance compared to the S&P 500).
* **Relative Performance:** 97.28% (indicating that HCA's current performance is at the 97.28 percentile of its historical performance relative to the S&P 500).

**2. Recent Price Movements:**

* **Closing Price:** $387.98
* **5-Day Moving Average:** $394.29 (slightly above the closing price, suggesting a potential short-term downward trend)
* **20-Day Moving Average:** $381.98 (below the closing price, indicating a potential short-term upward trend)
* **60-Day Moving Average:** $351.82 (significantly below the closing price, implying a longer-term upward trend)

**3. Technical Indicators:**

* **RSI:** 69.01 (slightly overbought, suggesting potential for a short-term correction)
* **PPO:** -0.18 (indicates a slight bearish sentiment, although the magnitude is minimal)
* **Delta_Previous_Relative_Divergence:** -2.72 (indicates a recent short-term downward trend in relative performance)
* **Expected Return:** 2.35% (indicates a potential 5-year maximum expected return for current investments)

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-07-29 | 5.6 | $17.49B |  * **Analyst estimates were not provided for this report.**
| 2024-05-02 | 6.01 | $17.34B |
| 2023-10-26 | 3.98 | $16.21B |
| 2023-08-02 | 4.35 | $15.86B |
| 2024-07-29 | 4.35 | $15.86B |

**Analysis:** HCA has shown steady revenue growth over the past year, with EPS increasing significantly in the most recent quarter. However, the stock price has exhibited some volatility recently. The relatively high RSI and negative Delta_Previous_Relative_Divergence suggest potential for a short-term correction. Nonetheless, the long-term trends are positive, with the price above all major moving averages, and the expected return remains encouraging. 

**5. Overall Analysis:**

HCA is a strong performer, outperforming the broader market significantly. The company has shown consistent revenue and earnings growth, and technical indicators suggest a potentially positive outlook despite some short-term volatility. Investors seeking exposure to the healthcare sector may find HCA to be a promising investment opportunity. However, it is important to monitor the short-term trend closely due to the potential for correction. 
